Nonstimulant Therapies for ADHD
Psychiatric Times
JUNE 30, 2025
Atomoxetine and viloxazine function as norepinephrine reuptake inhibitors, targeting neurotransmitter systems involved in attention, distractibility, and response inhibition. These medications offer particular benefits for patients with comorbid conditions or those who cannot tolerate stimulant side effects.
Let's personalize your content